Understanding how the immune system responds to SARS-CoV-2 infections
Early Drivers of Humoral Immunity to SARS-CoV-2 Infections
This study is looking at how our immune system reacts to the COVID-19 virus right after we're exposed, especially in people who don't show symptoms compared to those who do, to help us understand how long-lasting immunity develops.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Case Western Reserve University NIH-funded |
| Lab location | 1 site (Cleveland, United States) |
| Project ID | NIH-11145442 on NIH RePORTER |
What this research studies
This research investigates the early immune responses to SARS-CoV-2, particularly focusing on how the body produces antibodies immediately after exposure to the virus, even before symptoms appear. It aims to compare the immune responses of asymptomatic individuals with those who develop clinical illness, providing insights into the development of long-term immunity. The study involves analyzing blood and saliva samples to measure specific antibodies and viral loads, helping to identify factors that contribute to viral clearance and immune memory.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals who have been exposed to SARS-CoV-2, particularly those living in the same household as confirmed cases.
Not a fit: Patients who have not been exposed to SARS-CoV-2 or those with severe clinical illness may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of immunity to COVID-19, potentially leading to improved vaccines and treatments.
How similar studies have performed: Other research has shown promising results in understanding immune responses to viral infections, making this approach both relevant and potentially impactful.
Where this research is happening
Cleveland, United States
- Case Western Reserve University — Cleveland, United States (Active)
Researchers
- Principal investigator: King, Christopher L — Case Western Reserve University
- Study coordinator: King, Christopher L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.